|
Volumn 49, Issue 3, 2002, Pages 343-347
|
Circulating nuclear matrix protein in Graves' disease
a a a a |
Author keywords
Graves' disease; NMP; sFas; sFas ligand
|
Indexed keywords
FAS LIGAND;
NUCLEAR PROTEIN;
PLASMA PROTEIN;
THIAMAZOLE;
THYROID HORMONE;
THYROTROPIN RECEPTOR ANTIBODY;
AUTOANTIBODY;
FAS ANTIGEN;
FASLG PROTEIN, HUMAN;
MEMBRANE PROTEIN;
NUCLEAR MATRIX PROTEIN;
THYROTROPIN BINDING INHIBITORY IMMUNOGLOBULIN;
THYROTROPIN RECEPTOR;
THYROTROPIN-BINDING INHIBITORY IMMUNOGLOBULIN;
ADULT;
APOPTOSIS;
ARTICLE;
CELL DAMAGE;
CLINICAL ARTICLE;
CONTROLLED STUDY;
FEMALE;
GRAVES DISEASE;
HUMAN;
MALE;
THYROID FUNCTION;
THYROID HORMONE BLOOD LEVEL;
BLOOD;
CELL SURVIVAL;
MIDDLE AGED;
MONOCYTE;
PATHOPHYSIOLOGY;
PHYSIOLOGY;
REFERENCE VALUE;
SOLUBILITY;
ADULT;
ANTIGENS, CD95;
AUTOANTIBODIES;
CELL SURVIVAL;
FAS LIGAND PROTEIN;
FEMALE;
GRAVES DISEASE;
HUMANS;
MALE;
MEMBRANE GLYCOPROTEINS;
MIDDLE AGED;
MONOCYTES;
NUCLEAR MATRIX-ASSOCIATED PROTEINS;
RECEPTORS, THYROTROPIN;
REFERENCE VALUES;
SOLUBILITY;
THYROID HORMONES;
|
EID: 0036022466
PISSN: 09188959
EISSN: None
Source Type: Journal
DOI: 10.1507/endocrj.49.343 Document Type: Article |
Times cited : (7)
|
References (28)
|